Wearables + A.I. = Longer Life
INVEST IN YOURSELF
TulsaLabs to Develop Personalized Health Analytics Utilizing Artificial Intelligence
AppSwarm Inc. Press release content from NewMediaWire. The AP news staff was not involved in its creation.
READ FULL ARTICLE HERE:https://apnews.com/press-release/newmediawire/technology-health-media-software-artificial-intelligence-d27948aee2e430fe2ff1be50460e5f3d
Tulsa, OK – ( NewMediaWire ) – September 09, 2021 – AppSwarm, Corp. (OTC: SWRM ), a software development company and aggregator of mobile applications, announced it has been retained by GTX Corp (OTC: GTXO ), a pioneer in wearable technology and the health and safety wearable device market, to develop ‘health analytics’ utilizing artificial intelligence (A.I.) to assist in potentially extending the human life span.
Health data analytics, also known as clinical data analytics, involves the extrapolation of actionable insights from sets of patient data, typically collected from electronic devices, such as wearables.
Wearables can be employed from different body parts such as head-based, foot-based, eye-based, and wrist-based. Some examples of wearable data include steps taken, food and water intake, calories burned, sleep movement, and breathing. ADVERTISEMENT
TulsaLabs will utilize data generated from wearable devices and sensors to develop cloud-based analytics that will monitor and analyze a user’s health data through long-term dataset development, utilizing artificial intelligence. The A.I. powered platform will then allow users to look for potential trends that can then be offset with lifestyle adjustments to prevent the onset of some of the most common metabolic diseases such as diabetes, heart disease, and obesity.
“We are very excited at the idea of utilizing artificial intelligence and wearable data to help people live better and even possibly longer lives. Through predictive analytics, users will be able to find the best course of action for health on an individual basis. Developing personalized health data will assist users in avoiding some of the more common causes of metabolic diseases and help increase the quality-of-life for individuals, and society,” stated Chris Bailey, the CEO of AppSwarm.
Patrick Bertagna, the CEO of GTX Corp, commented, “One thing COVID has brought to the forefront is how important health is to our longevity, so combining A.I. with wearables will greatly enhance our ability to develop and bring to market powerful health and wellness solutions. We look forward to working with Chris’s team and having them join the longevity revolution with us.”
About APPSWARM
AppSwarm is a technology company specializing in accelerated development and publishing of mobile apps and other software platforms for gaming and business applications and seeks to acquire symmetric business opportunities. AppSwarm partners with and assists other development firms in technology development, business management, and funding needs.
MetAlert (OTC: MLRT) and its subsidiary Level 2 Security occupy a commanding position in the design, development, manufacturing, distribution, sales, and IP licensing of GPS wearable technology, firearm and mobile asset recovery solutions, remote patient monitoring technology, and health data collection. With years of industry expertise and a robust portfolio of patents, MetAlert is the go-to solution provider for government, enterprise and consumers grappling with mobility, cognitive, and spatial awareness challenges, which currently represents approximately 2.9% of the global population. The Company delivers comprehensive turnkey solutions encompassing logistics, hardware, software, and connectivity.
Notable achievements include the groundbreaking GPS SmartSole®, a fusion of Dr. Scholl’s comfort with LoJack’s tracking prowess. It stands as the world’s inaugural invisible wearable tracking device, designed for individuals susceptible to wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. And MyGunAlert the first patented lockable, motion sensitive, firearm recovery device supported by law enforcement.
MetAlert’s subscription-based model thrives on technology innovation fortified by intellectual property safeguards. The company boasts international distribution channels serving customers across 40 countries, alongside its role as a U.S. Military Government contractor. In addition to public health entities, MetAlert caters to municipalities, emergency and law enforcement agencies, private and public educational institutions, assisted living facilities, NGOs, senior care residences, consumers, and small enterprises. Recognizing its capacity within its distribution center and backend subscription processing also presents an opportunity to provide backend services for other subscription based enterprises.
General information, investor relations, wholesale licensing, consumer purchase:
213.489.3019 | Info@MetAlert.com | IR@MetAlert.com | Contact Us
MetAlert.com | Mygunalert.com | Track My Workforce | GPS SmartSole.com
MetAlert United Kingdom– In the UK, MetAlert operates from its London office.
Please contact: Nelson Skip Riddle | Email: NSRiddle@MetAlert.com | Tel: +44 7785 364100
Level 2 Security (Wholly owned subsidiary) Email: contactus@level2sec.com | www.mygunalert.com | www.ifitmoves.com
Forward Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document’s content will not infringe the rights of third parties who are not owned or affiliated by MetAlert. Further, MetAlert cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.